Patents by Inventor Nathaniel L. Wilganowski

Nathaniel L. Wilganowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020161214
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Application
    Filed: October 30, 2001
    Publication date: October 31, 2002
    Inventors: D. Wade Walke, Nathaniel L. Wilganowski, Carl Johan Friddle
  • Publication number: 20020127674
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications
    Type: Application
    Filed: January 30, 2002
    Publication date: September 12, 2002
    Inventors: Xuanchuan Yu, Maricar Miranda, Nathaniel L. Wilganowski
  • Patent number: 6444456
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Grant
    Filed: March 8, 2001
    Date of Patent: September 3, 2002
    Assignee: Lexicon Genetics Incorporated
    Inventors: D. Wade Walke, Nathaniel L. Wilganowski, C. Alexander Turner, Jr.
  • Publication number: 20020098486
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Application
    Filed: February 28, 2001
    Publication date: July 25, 2002
    Inventors: Gregory Donoho, Erin Hilbun, C. Alexander Turner, Glenn Friedrich, Alejandro Abuin, Brian Zambrowicz, Arthur T. Sands, D. Wade Walke, Nathaniel L. Wilganowski, Yi Hu, James Alvin Kieke, David George Potter
  • Publication number: 20020042503
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Application
    Filed: March 8, 2001
    Publication date: April 11, 2002
    Inventors: D. Wade Walke, Nathaniel L. Wilganowski, C. Alexander Turner
  • Publication number: 20020042504
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in thrapeutic, diagnostic, and pharmacogenomic applcations.
    Type: Application
    Filed: March 20, 2001
    Publication date: April 11, 2002
    Inventors: D. Wade Walke, Nathaniel L. Wilganowski, C. Alexander Turner, Erin Hilbun, Xiaoming Wang, Gregory Donoho, John Scoville
  • Publication number: 20020040131
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in thereapeutic, diagnostic, and pharmacogenomic applications.
    Type: Application
    Filed: April 12, 2001
    Publication date: April 4, 2002
    Inventors: D. Wade Walke, Nathaniel L. Wilganowski, C. Alexander Turner
  • Publication number: 20010034437
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Application
    Filed: January 5, 2001
    Publication date: October 25, 2001
    Inventors: D. Wade Walke, Nathaniel L. Wilganowski, Gregory Donoho, C. Alexander Turner
  • Publication number: 20010034438
    Abstract: The nucleotide and amino acid sequences of a novel human G protein-coupled receptor (NGPCR) is disclosed. The NGPCR is somewhat similar to human latrophilin, lectomedin, and serpentine, proteins, among others.
    Type: Application
    Filed: January 5, 2001
    Publication date: October 25, 2001
    Inventors: D. Wade Walke, Nathaniel L. Wilganowski, C. Alexander Turner, Glenn Friedrich, Alejandro Abuin, Brian Zambrowicz, Arthur T. Sands